Remitting seronegative symmetrical synovitis with pitting edema syndrome in individuals with type 2 diabetes mellitus or impaired glucose tolerance. Issue 1 (October 2015)

• Record Type: Journal Article
• Authors: Oyama, Kohta; Taniguchi, Jun-ichi; Goto, Rieko; Matsui, Kunihiko
• Is Part Of: Diabetes research and clinical practice. Volume 110:Issue 1(2015)
• Page Start: e5
• Page End: e8
• Publication Date: 2015-10
• Subjects: Remitting seronegative symmetrical synovitis with pitting edema -- Diabetes mellitus -- Impaired glucose tolerance; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.06.007
• Languages: English
• ISSNs: 0168-8227

Abstract

Highlights: An association between remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and insulin or dipeptidyl peptidase-4 (DPP4) inhibitor therapy was previously reported. We report four cases of RS3PE syndrome with type 2 diabetes mellitus or impaired glucose tolerance (IGT) without insulin or DPP4 inhibitor medication. RS3PE syndrome might be associated with diabetes, regardless of type or anti-diabetes therapies. Abstract: An association between remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and insulin or dipeptidyl peptidase-4 (DPP4) inhibitor therapy were previously reported. We encountered four cases of RS3PE syndrome with type 2 diabetes mellitus or impaired glucose tolerance (IGT) without insulin or DPP4 inhibitor medication.